Inflammatory Breast Cancer: Pathogenesis, Diagnosis, and Therapeutic Advances

This track will delve into the pathogenesis, diagnosis, and therapeutic advances in inflammatory breast cancer (IBC). Participants will gain insights into the unique characteristics of IBC, including its aggressive nature and distinctive clinical presentation. The discussions will focus on unraveling the underlying molecular mechanisms contributing to IBC development and progression. Diagnostic challenges, such as differentiating IBC from other breast malignancies, will be addressed, emphasizing the importance of accurate and timely diagnosis. Furthermore, cutting-edge therapeutic strategies and emerging treatment modalities specific to IBC will be explored, highlighting the latest advancements and clinical trials that aim to improve outcomes for patients with this challenging form of breast cancer.

  • Pathogenic Mechanisms and Molecular Signatures
  • Diagnostic Challenges and Advances

Related Conference of Inflammatory Breast Cancer: Pathogenesis, Diagnosis, and Therapeutic Advances

March 10-11, 2025

3rd World Congress on Oral Cancer

Paris, France
March 24-25, 2025

25th World Congress on Cancer and Diagnostics

London, UK
March 24-25, 2025

10th World Conference on Breast and Cervical Cancer

Paris, France
April 07-08, 2025

15th World Congress on Breast Cancer

Vancouver, Canada
April 28-29, 2025

35th Experts Meet On Cancer Research & Therapy

Aix-en-Provence, France
June 16-17, 2025

26th World Congress on Cancer Summit

Amsterdam, Netherlands
July 14-15, 2025

5th World Congress on Breast Cancer

Berlin, Germany
July 28-29, 2025

45th Euro Congress on Cancer Science & Therapy

Aix-en-Provence, France
October 20-21, 2025

21st International Conference on Cancer Research

Barcelona, Spain

Inflammatory Breast Cancer: Pathogenesis, Diagnosis, and Therapeutic Advances Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in